Colchicine Dosing for Acute Gout: Two Doses Only
For acute gout flares, give colchicine 1.2 mg immediately, followed by 0.6 mg one hour later—that's it, just two doses totaling 1.8 mg. Do not continue dosing every hour beyond this initial regimen.
The Evidence-Based Regimen
The FDA-approved dosing and multiple guidelines converge on this low-dose approach 1, 2:
- Initial dose: 1.2 mg (two 0.6 mg tablets)
- Second dose: 0.6 mg (one tablet) one hour later
- Total: 1.8 mg over one hour
- Frequency: This is a single treatment course, not repeated more than once every 3 days
This regimen achieves the same efficacy as the old high-dose protocol (4.8 mg over 6 hours) but with dramatically fewer gastrointestinal side effects 3. The landmark trial showed 38% of patients achieved ≥50% pain reduction at 24 hours with low-dose colchicine versus only 16% with placebo, while adverse events were similar to placebo 3.
What Happens After the Initial Two Doses
If the patient is NOT already on prophylactic colchicine: Wait 12 hours after the second dose, then you can start prophylactic dosing at 0.6 mg once or twice daily until the flare completely resolves 4.
If the patient IS already on prophylactic colchicine: Choose a different therapy (NSAID or corticosteroid) instead 4.
Critical Timing Factor
Start colchicine within 12-36 hours of flare onset for maximum benefit 4, 5, 4. The 2016 EULAR guidelines specifically recommend starting within 12 hours 5. Beyond 36 hours, efficacy drops significantly and alternative therapies should be considered.
Dose Adjustments for Renal Impairment
This is where many clinicians make dangerous errors. The standard two-dose regimen requires modification:
Mild-moderate renal impairment (CrCl 30-80 mL/min):
- Use the standard 1.2 mg + 0.6 mg regimen
- Monitor closely for adverse effects
- Do not repeat the treatment course more than once every 2 weeks 2
Severe renal impairment (CrCl <30 mL/min):
- Reduce to a SINGLE dose of 0.6 mg
- Do not give the second 0.6 mg dose
- Do not repeat more than once every 2 weeks 2
Dialysis patients:
- Single 0.6 mg dose only
- Do not repeat more than once every 2 weeks 2
Drug Interactions That Demand Dose Reduction
If the patient is taking strong CYP3A4 or P-glycoprotein inhibitors (clarithromycin, cyclosporine, ritonavir, ketoconazole), the FDA label mandates dose adjustments 2:
- For acute flare: 0.6 mg × 1 dose, then 0.3 mg one hour later (total 0.9 mg)
- Do not repeat for at least 3 days
- In patients with renal or hepatic impairment taking these inhibitors: Do not use colchicine at all 2
Common Pitfalls to Avoid
The "old school" hourly dosing: The 0.6 mg every hour until diarrhea or relief regimen is obsolete and dangerous. It causes severe GI toxicity with no additional benefit 3.
Treating through prophylaxis: If a patient on prophylactic colchicine develops a flare, adding more colchicine for acute treatment is not recommended—switch to NSAIDs or corticosteroids 4.
Ignoring renal function: Real-world data shows physicians frequently prescribe excessive colchicine doses in renal impairment 6. Always calculate CrCl before dosing.
Repeating too soon: The treatment course should not be repeated within 3 days in normal renal function, or within 2 weeks in renal impairment 2.
Alternative First-Line Options
The 2017 ACP guidelines actually recommend considering corticosteroids as first-line therapy due to better safety profile and lower cost 1. NSAIDs are equally effective 1. The choice between colchicine, NSAIDs, and corticosteroids should be based on contraindications and patient factors, not a rigid hierarchy.
For patients who cannot take oral medications, use parenteral corticosteroids (intramuscular, intravenous, or intra-articular) 7.